<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01997320</url>
  </required_header>
  <id_info>
    <org_study_id>H-4-2013-068</org_study_id>
    <nct_id>NCT01997320</nct_id>
  </id_info>
  <brief_title>Effect of Strength Training and Protein Supplementation on Muscles in the Very-old</brief_title>
  <acronym>83+</acronym>
  <official_title>Effect of Strength Training and Protein Supplementation on the Muscle Function in Very Old Nursinghome Residents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Three months intervention study, investigating the effect of nutrient supplementation
      (including 20g of milk protein) twice daily with or without additional heavy resistance
      exercise three times weekly on muscle size, structure and function in 30 subjects at least 83
      years of age.

      Primary hypothesis is that the group conducting exercise improves muscle size, structure and
      function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 30 subjects at least 83 years of age are recruited using advertisements in
      newspapers, magazines, public places and further personal contact. After information and
      written ethical consent (in accordance with the Declaration of Helsinki II) health status is
      evaluated by a medical doctor including blood screening, screening for dementia and routine
      objective evaluation. If there is no reason to exclude subjects (see exclusion criteria),
      they are whole-body DXA-scanned (Dual X-ray Absorptiometry) and MR-scanned (Magnetic
      resonance imaging)(dominant knee and femur) and functional measures (30s chair-stand, 10m and
      8m gait speed, DEMMI-test) and strength measures (isometric and isokinetic leg power, power
      rig, grip strength) and tendon stiffness are measured. At least 4 days after this the first
      muscle biopsy in the dominant m. vastus lateralis is taken. Hereafter subjects are randomized
      to one of two groups:

      Group one (n=15) is the exercise and nutrition group (HRT). Subjects in this group are to
      conduct supervised center-based heavy resistance exercise of the lower extremities three
      times weekly for 12 weeks. As for group two, this group receives nutritional supplementation
      twice daily throughout the 12 weeks period. Supplementation contains 20g of milk protein and
      some carbohydrate and lipids.

      Group two (n=15) is the nutrition group (PRO). Subjects in this group only receives
      nutritional supplementation as described above.

      After 12 weeks of intervention the same strength- and functional measures are made, DXA- and
      MR-scans and a second biopsy is made along with tendon stiffness measurement.

      Data is collected and analyzed by staff blinded to randomization. Personal data is locked up,
      and only anonymized data is analyzed. Differences in both primary (m. quadriceps femoris
      cross sectional area) and secondary outcomes (functional measures, strength measures, muscle
      cell- and fiber type count, mRNA expression, muscle collagen content and distribution) are
      evaluated using two-way anova with repeated measures and, if allowed, post-hoc tests.
      Analysis will be made as intention-to-treat.

      Power:

      With an expected 10% increase in quadriceps CSA (cross-sectional area) (from 4500 square mm
      at baseline) with a SD of 600 square mm, power is 82% with alfa 0.05 with inclusion of 15
      subjects in each group.

      In case of systematic health-issues in response to the intervention, the trial will end
      immediately.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in quadriceps muscle cross sectional area from baseline to 3 months</measure>
    <time_frame>0 and 3 months</time_frame>
    <description>Assessed by MRI scanning of dominant thigh. 8 slices, each of 1cm thickness, separated by 5cm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in isometric muscle strength from baseline to 3 months</measure>
    <time_frame>0 and 3 months</time_frame>
    <description>Unilateral measurement of isometric strength in m. quadriceps femoris using KinCom.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in isokinetic muscle strength from baseline to 3 months</measure>
    <time_frame>0 and 3 months</time_frame>
    <description>Unilateral isokinetic muscle strength at 60 degrees/s of m. quadriceps femoris.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in leg power from baseline to 3 months</measure>
    <time_frame>0 and 3 months</time_frame>
    <description>Using a Powerrig, unilateral leg extension power is determined.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in gait speed from baseline to 3 months</measure>
    <time_frame>0 and 3 months</time_frame>
    <description>Gait speed averaged over 10m including acceleration. Gait speed averaged over 8m excluding acceleration.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in DEMMI from baseline to 3 months</measure>
    <time_frame>0 and 3 months</time_frame>
    <description>DeMorton Mobility Index</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in 30s chair-stand from baseline to 3 months</measure>
    <time_frame>0 and 3 months</time_frame>
    <description>30s chair-stand</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Short Form-36 questionnaire from baseline to 3 months</measure>
    <time_frame>0 and 3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in patella tendon stiffness from baseline to 3 months</measure>
    <time_frame>0 and 3 months</time_frame>
    <description>Stress-deformation of dominant patella tendon using ultrasound.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in muscle biopsy from baseline to 3 months</measure>
    <time_frame>0 and 3 months</time_frame>
    <description>Measurements of fiber types, size, capillary density, satellite cell count, mRNA-targets, western blotting, muscular collagen content and distribution.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in standard health parameters from baseline to 3 months</measure>
    <time_frame>0 and 3 months</time_frame>
    <description>Blood pressure, plasma lipids, HbA1c, anthropometry</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Ageing</condition>
  <arm_group>
    <arm_group_label>Heavy resistance exercise and nutrition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Heavy resistance exercise of the lower extremities three times weekly for 12 weeks combined with nutrient supplementation twice daily each containing 20g of milk protein.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nutrition supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nutrient supplementation twice daily for 12 weeks. Each supplement contains 20g of milk protein.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Heavy resistance exercise and nutrition</intervention_name>
    <description>Heavy resistance exercise of the lower extremities three times weekly for 12 weeks.</description>
    <arm_group_label>Heavy resistance exercise and nutrition</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutrition supplement</intervention_name>
    <description>Two daily administrations of nutrient supplementation, each containing 20g of milk protein.</description>
    <arm_group_label>Nutrition supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age at least 83 years

        Exclusion Criteria:

          -  Acute severe medical or surgical illnesses.

          -  Unstable chronic diseases, eg. renal failure, uncontrolled cardiac arrythmias, severe
             COPD (Chronic Obstructive Pulmonary Disease), diabetes mellitus.

          -  Bilateral knee alloplastics

          -  Metal devices compromising MR-scanning.

          -  Medicine: Anticoagulants (K-vitamin antagonists, heparins, ADP-receptor blockers,
             direct thrombin inhibitors, factor Xa inhibitors), systemic steroid treatment.

          -  Dementia

          -  Regular heavy load resistance exercise more than 20 min/week.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>83 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Kjaer, MD, Proff.</last_name>
    <role>Study Chair</role>
    <affiliation>Head of department</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Sports Medicine Copenhagen, Bispbebjerg Hospital</name>
      <address>
        <city>Copenhagen NV</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 11, 2013</study_first_submitted>
  <study_first_submitted_qc>November 27, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 28, 2013</study_first_posted>
  <last_update_submitted>October 9, 2015</last_update_submitted>
  <last_update_submitted_qc>October 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Rasmus Leidersdorff Bechsh√∏ft</investigator_full_name>
    <investigator_title>M.D., Ph.d. student</investigator_title>
  </responsible_party>
  <keyword>Sarcopenia</keyword>
  <keyword>Frailty</keyword>
  <keyword>Strength</keyword>
  <keyword>Protein supplementation</keyword>
  <keyword>Ageing</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

